JANX

Janux Therapeutics
JANX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.40B
EV
$429.37M
Shares Outstanding
62.42M
Beta
2.85

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$82.46
P/E 2025E
-
P/Revenue 2025E
247.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Janux Therapeutics, Inc.

gainify
JANX

Janux Therapeutics, Inc.

JANX

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company’s c...

Sector

Healthcare

Industry

Biotechnology

CEO

Campbell, David

Employees

103

IPO Date

2021-06-11

Headquarters

10955 Vista Sorrento Parkway, Suite 200, San Diego, California, 92130, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.